RT Book, Section A1 Rumore, Martha M. A2 Malone, Patrick M. A2 Malone, Meghan J. A2 Park, Sharon K. SR Print(0) ID 1151745332 T1 Legal Aspects of Drug Information Practice T2 Drug Information: A Guide for Pharmacists, 6e YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9781259837975 LK accesspharmacy.mhmedical.com/content.aspx?aid=1151745332 RD 2024/03/29 AB After completing this chapter, the reader will be able toDescribe the legal issues related to the provision of drug information (DI).Apply various legal theories that impose liability on pharmacists providing DI.Describe how pharmacists can help protect themselves from malpractice claims resulting from the provision of DI.Explain the Doctrine of Drug Overpromotion as it pertains to the 1997 Food and Drug Administration (FDA) Modernization Act (FDAMA).Identify the liability concerns inherent with off-label drug use and informed consent.Describe U.S. copyright law as it pertains to the provision of DI.Identify copyright, liability, and privacy issues arising from the Internet and social media.Describe the legal and ethical challenges emerging in telemedicine and cybermedicine.Describe the DI plan that addresses the Health Insurance Portability and Accountability Act (HIPAA) of 1996.Explain the legal issues involved with industry support for pharmaceutical educational activities.